Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Dresser-Rand Appoints Jan Kees Van Gaalen As CFO

RELATED NEWS
Trade DRC now with 

Dresser-Rand Group Inc. (DRC: Quote) a provider of engineered rotating equipment solutions, Wednesday announced the appointment of Jan Kees van Gaalen as Executive Vice President and Chief Financial Officer, effective May 1. He takes over from Mark Baldwin, whose impending retirement was earlier made public.

Van Gaalen previously worked for Baker Hughes Inc., a public company and provider of drilling, formation evaluation, completion and production products and services to the oil and gas industry, where he served as Vice President and Treasurer.

Commenting on the development, Vincent Volpe, Jr., Dresser-Rand's CEO said, "Jan Kees' knowledge of our industry, along with his strong financial and operational pedigree and vast international experience provides him a solid platform for the role of Chief Financial Officer of Dresser-Rand." and, thanking the retiring CFO said, "...I am also pleased that Mark will be available to assist the company during the transition period with Jan Kees."

Click here to receive FREE breaking news email alerts for Dresser-Rand Group Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Proctor and Gamble (PG) has sold two of its soap brands to European consumer products giant Unilever (UN). Cincinnati-based P&G says the sale includes the global Camay brand, the Zest brand outside of North America and its Talisman manufacturing plant in Mexico. The plant employs approximately... Dish Network is no longer carrying Fox News in yet another dispute for the television provider. Fox News, which changed the face of cable news with its ardent advocacy of conservative issues, went dark Sunday, replaced on Dish by The Blaze, Glen Beck's new right-leaning channel. Fox Business channel... Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.